Wang, Liye
Hong, Ruoxi
Shi, Simei
Wang, Shusen
Chen, Yong
Han, Chao
Li, Mei
Ye, Feng
Article History
Received: 18 February 2024
Accepted: 16 August 2024
First Online: 29 August 2024
Declarations
:
: Study protocols were approved by the ethical committee of Sun Yat-Sen University Cancer Center and written informed consent was obtained from all participants involved in this study (Ethics Approval ID: B2021-062). All procedures in this study were conducted in accordance with ethical principles.
: Not required.
: Chao Han has financial interests in AnFang Biotech. All other authors declare that they have no competing interests.